TIA
CVS icon

Traphagen Investment Advisors’s CVS Health CVS Stock Holding History

Traphagen Investment Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$300K Buy
2,904
+3
+0.1% +$268 0.02% 168
2026
Q1 		$208K Buy
2,901
+1
+0% +$77 0.02% 192
2025
Q4 		$230K Buy
2,900
+26
+0.9% +$2.05K 0.02% 177
2025
Q3 		$217K Buy
+2,874
New +$197K 0.02% 179
2024
Q2 		– Sell
-3,393
Closed -$271K – 178
2024
Q1 		$271K Buy
3,393
+152
+5% +$11.6K 0.03% 145
2023
Q4 		$256K Buy
3,241
+236
+8% +$16.8K 0.03% 146
2023
Q3 		$210K Sell
3,005
-865
-22% -$61.3K 0.03% 147
2023
Q2 		$268K Buy
+3,870
New +$275K 0.03% 128
2022
Q4 		– Sell
-2,259
Closed -$215K – 143
2022
Q3 		$215K Sell
2,259
-114
-5% -$11.3K 0.04% 129
2022
Q2 		$220K Sell
2,373
-67
-3% -$6.54K 0.04% 129
2022
Q1 		$247K Buy
2,440
+329
+16% +$34.6K 0.04% 120
2021
Q4 		$218K Buy
+2,111
New +$195K 0.04% 134
2019
Q2 		– Sell
-3,849
Closed -$208K – 112
2019
Q1 		$208K Buy
+3,849
New +$238K 0.06% 99

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Traphagen Investment Advisors's CVS Position: Q2 2026 in Review

Traphagen Investment Advisors increased its CVS Health (CVS) stake by 0.1% in Q2 2026, buying an estimated $268 and bringing the position to 2,904 shares worth $300K. The position accounts for 0.02% of the portfolio, ranked #168.

Traphagen Investment Advisors first reported a position in CVS in Q1 2019 and has held it in 13 quarters since. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • Traphagen Investment Advisors held 2,904 shares of CVS Health worth $300K as of Q2 2026.
  • Traphagen Investment Advisors bought 3 CVS Health shares in Q2 2026, an estimated $268.
  • CVS Health made up 0.02% of Traphagen Investment Advisors's portfolio in Q2 2026, its #168 holding.
  • Traphagen Investment Advisors first reported a position in CVS Health in Q1 2019 and has held it in 13 quarters since.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on Traphagen Investment Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.